Uptake of 13-hydroperoxylinoleic acid by cultured cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 925-931

  Augé, Nathalie ^a,b   Santanam, Nalini ^a   Mori, Natsuko ^a   Keshava, Channa ^a,c   Parthasarathy, Sampath ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

13 hydroperoxyoctadecadienoic acid; Atherosclerosis; Endothelial cells; Linoleic acid; Macrophages

Indexed keywords

1 ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE; 13 HYDROPEROXYLINOLEIC ACID; CD36 ANTIGEN; LINOLEIC ACID; OLEIC ACID; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL METABOLISM; CELL SURFACE; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0032918513     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.925     Document Type: Article

References (55)

1. Nakao J, Ooyama T, Ito H, Chang W, Murota S. Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration. Atherosclerosis. 1982;44:339-343.
2. Nishio E, Watanabe Y. Role of the lipoxygenase pathway in phenylephrine-induced vascular smooth muscle cell proliferation and migration. Eur J Pharmacol. 1997;336:267-273.
3. Rao GN, Baas AS, Glasgow WC, Eling TE, Runge MS, Alexander RW. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J Biol Chem. 1994;269: 32586-32591.
4. Rao GN, Glasgow WC, Eling TE, Runge MS. Role of hydroperoxyeicosatetraenoic acids in the oxidative stress-induced activating protein-1 (AP-1) activity. J Biol Cliem. 1996;54:155-166.
5. Rao GN, Alexander RW, Runge MS. Linoleic acid and its metabolite, hydroeicosatetraenoic acid, stimulate c-Fos, c-Jun. and c-Myc mRNA expression, mitogen-activated protein, protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest. 1995;96:842-847.
6. Ramasamy S, Lipke DW, Boissonneault GA, Quo H, Hennig B. Oxidized lipid-mediated alterations in proteoglycan metabolism in cultured pulmonary endothelial cells. Atherosclerosis. 1996;120:199-208.
7. Khan BV, Parthasarathy S, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 1995;95:1262-1270.
8. Ramasamy S. Parthasarathy S, Harrison DG. Regulation of endothelial nitric oxide synthetase gene expression by oxidized linoleic acid. J Lipid Res. 1998;39:268-276.
9. Sandstrom PA, Pardi D, Tebbey PW, Dudek RW, Terrian DM, Folks TM, Buttke TM. Lipid hydroperoxide-induced apoptosis; lack of inhibition by Bcl-2 over-expression. FEBS Lett. 1995;365:66-70.
10. Ku G, Thomas CE, Akeson AL, Jackson RL. Induction of interleukin-1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroeicosatetraenoic acid. J Biol Chem. 1992;267:14183-14188.
11. Gorog P. Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for the generation of lipids peroxides in the circulation. Int J Exp Pathol. 1991;72:227-237.
12. Thomas CE, Jackson RL, Ohlweiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J Lipid Res. 1994;35:417-427.
13. Coene MC, Bult H, Claeys M, Laekeman GM, Herman AG. Inhibition of rabbit platelet activation by lipoxygenase products of arachidonic and linoleic acid. Thromb Res. 1986;42:205-214.
14. Aoshima H, Satoh T, Sakai N, Enokido Y, Ikeuuchi T, Hatanaka H. Generation of free radicals during lipid hydroperoxide-triggered apoptosis in PC12h cells. Biochem Biophys Acta. 1997;1345:35-42.
15. Wen Y, Scott S, Liu Y, Gonzales N, Nadler J. Evidence that angiotensin II and lipoxygenase products activate c-Jun NH2-terminal kinase. Circ Res. 1997;81:651-655.
16. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 1990;3:77-92.
17. Parthasarathy S. Modified Lipoproteins in the Pathogenesis of Atherosclerosis. Austin, Tex: RG Landes; 1994:1-125.
18. Gordon EE, Gordon JA, Spector AA. HETEs and coronary artery endothelial cells: metabolic and functional interactions. Am J Physiol. 1991; 261:C623-C633.
19. Mathur SN, Field FJ, Spector AA, Armstrong ML. Increased production of lipoxygenase products by cholesterol-rich mouse macrophages. Biochim Biophys Acta. 1985;837:13-19.
20. Folcik VA, Nivar-aristy RA, Krajewski LP, Cathcart MK. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaque. J Clin Invest. 1995;96:504-510.
21. Sigal E, Laughton CW, Mulkins MA. Oxidation, lipoxygenase, and atherogenesis. Ann NY Acad Sci. 1994;714:211-224.
22. Mown HK, Chinen K, Ohkuma S, Takano T. Peroxidized lipids isolated by HPLC from atheroclerotic aorta. Biochem Acta. 1986;12:347-352.
23. Stein O, Haratz D, Shwartz R, Berry EM, Stein Y. Modification of cellular fatty acid composition of Hep-G2 cells: effect of antioxidants on cholesterol esterification and secretion. Biochim Biophys Acta. 1989;1003:115-120.
24. Haas TA, Bastida E, Nakamura K, Hullin F, Admirall L, Buchanan MR. Binding of 13-HODE and 5-, 12-and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim Biophys Acta. 1988;961:153-159.
25. Mathur SN, Albright E, Field FJ. Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA: cholesterol acyltransferase in cholesterol-rich macrophages. Biochem J. 1988;256:807-814.
26. Richards CF, Johnson AR, Campbell WB. Specific incorporation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid into phosphatidylcholine in human endothelial cells. Biochim Biophys Acta. 1986;875:569-581.
27. Bafor M, Smith MA, Jonsson L, Stobart K, Stymne S. Ricinoleic acid biosynthesis and triacylglycerol assembly in microsomal preparation from developing castor bean (Ricinus communis) endosperm. Biochem J. 1996;280:507-514.
28. Swerlick RA, Lee KH, Wick TM, Lawley TJ. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol. 1992;148:78-83.
29. Santanam N, Parthasarathy S. Paradoxical actions of antioxidant in the oxidation of low density lipoprotein by peroxidase. J Clin Invest. 1995; 95:2594-2600.
30. Pitas RE, Friera A, McGuire J, Dejager S. Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts. Arterioscler Thromb. 1992;12:1235-1244.
31. Bligh EG, Dyer WJ. Rapid method to total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
32. Folch J, Lees M, Sloane-Standley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957; 226:497-509.
33. Parthasarathy S, Cady RK, Kraushaar DS, Sladek NE, Baumann WJ. Inhibition of diacylglycerol; CDP choline cholinephosphotransferase activity by dimethylaminoethyl p-chlorophenoxyacetate. Lipids. 1978;13:161-164.
34. Smith PK, Khon RI, Hermanson GT, Mallia, AK, Gartner FG, Provezano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Ann Biochem. 1985;150:76-85.
35. Parthasarathy S, El-Rahman A, Baumann WJ, Modulation of phosphatidylcholine synthesis in vitro. Inhibition of diacylglycerol cholinephosphotransferase and lysophosphatidylcholine acyltransferase by centrophenoxine and neophenoxine. Biochim Biophys Acta. 1981;665:345-351.
36. Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase (s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res. 1991;32:1361-1369.
37. Natarajan R, Gonzales N, Lanting L, Nadler J. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension. 1994;23:I-142-I-147.
38. Parthasarathy S, Wieland E, Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A. 1989;86:1046-1050.
39. Jaakkola O, Nikkari T. Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions. Am J Pathol. 1990;137:457-465.
40. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
41. Goldstein JL, Basu SK, Brown MS. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98:241-260.
42. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
43. Folcik VA, Cathcart MK. Predominance of esterified hydroperoxylinoleic acid in human monocyte-oxidized LDL. J Lipid Res. 1994;35: 1570-1582.
44. Parthasarathy S, Printz, D, Boyd L, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 1986;6:505-510.
45. Tabas I, Boykow GC, Tall AR. Foam cell forming J774 macrophages have markedly elevated acyl coenzyme A: cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein despite similar receptor activity. J Clin Invest. 1987;79:418-426.
46. Nicholson AC, Frieda S, Pearce A, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol. 1995;15:269-275.
47. Ryeom SW, Silverstein R, Scotto A, Sparrow JR. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem. 1996;271:20536-20539.
48. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
49. Ibrahimi A, Sfeir Z, Magharaie H, Amri EZ, Grimaldi P, Abumrad NA. Expression of the CD36 homolog (FAT) in fibroblasf cells: effects on fatty acid transport. Proc Natl Acad Sci U S A. 1996;93:2646-2651.
50. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N. Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot Essent Fatty Acids. 1997;57:17-21.
51. Gordon JA, Figard PH, Spector AA. Hydroeieosatetraenoic acid metabolism in cultured human skin fibroblast. Evidence for peroxisomal beta-oxidation. J Clin Invest. 1993;85:1173-1181.
52. Carpenter KL, Wilkins GM, Fussell B, Ballantine JA, Taylor SE, Mitchinson MJ, Leake DS. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem J. 1994;304:625-633.
53. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen, CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
54. Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K. Evidence for human thromboxane receptor heterogeneity using a novel series of 9, 11-cyclic carbonate derivatives of prostaglandin F2 alpha. Br. J Pharmacol. 1996; 117:1171-1180.
55. Santanam N, Auge N, Zhou M, Keshava C, Parthasarathy S. Overexpression of human catalase gene decreases oxidized lipid-induced cytotoxicity in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. In press.